Kosei Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 08-12-2024
- Paid Up Capital ₹ 3.36 M
as on 08-12-2024
- Company Age 8 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -35.88%
(FY 2020)
- Profit 142.87%
(FY 2020)
- Ebitda 507.37%
(FY 2020)
- Net Worth 29.51%
(FY 2020)
- Total Assets 15.69%
(FY 2020)
About Kosei Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.36 M, as per Ministry of Corporate Affairs (MCA) records.
Ranjeetkumar Sharma and Ranjana Trivedi serve as directors at the Company.
- CIN/LLPIN
U24290GJ2016PTC094459
- Company No.
094459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kosei Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjeetkumar Sharma  | Additional Director | 11-Mar-2024 | Current |
| Ranjana Trivedi | Additional Director | 11-Mar-2024 | Current |
Financial Performance and Corporate Structure Insights of Kosei Pharma.
Kosei Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 35.88% decrease. The company also saw a substantial improvement in profitability, with a 142.87% increase in profit. The company's net worth Soared by an impressive increase of 29.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kosei Pharma?
In 2020, Kosei Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Verimatrix Video Security Solutions India Private LimitedActive 11 years 7 monthsRanjeetkumar Sharma is a mutual person
Ipc Information Systems India Private LimitedActive 16 years 9 monthsRanjeetkumar Sharma is a mutual person
Coastal Marine Construction And Engineering LimitedActive 29 years 9 monthsRanjeetkumar Sharma is a mutual person
Mhg Management (India) Private LimitedActive 9 years 4 monthsRanjeetkumar Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kosei Pharma?
Unlock and access historical data on people associated with Kosei Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kosei Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kosei Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_377839.webp){kind=small}
